The Florida Institute for the Commercialization of Public Research, a nonprofit based in Gainesville and Boca Raton linking Florida’s private research institutions with state universities, recently reached a funding agreement with Boca Raton’s Ovation Diagnostics.
Ovation strives to improve outcomes for women diagnosed with ovarian cancer. The company is currently developing a lab test to allow women a noninvasive, affordable test with greater accuracy than that of existing diagnostic methods.
"Early and accurate detection is essential for success in treatment of ovarian cancer," Joseph Zack, Ovation Diagnostics president, said. “Unfortunately the majority of existing tests lack the ability to accurately detect the cancer in its early stages which results in lower survival rates. Our hope is this test may make a difference in earlier detection."
Florida Institute’s CEO Dr. Jackson Streeter called Ovation’s venture a “novel technology” with the potential to positively impact survival rates. Ovation secured a licensing agreement from University of South Florida in 2015.
Established by the Florida Legislature in 2007, the Institute directly supports development of new business entities dependent on publicly funded research and assists early-stage funding for companies created in affiliation with Florida institutions of research and higher education, acting as a liaison between research groups and the state university system’s technology licensing and commercialization departments.
Want to get notified whenever we write about Florida Institute for the Commercialization of Public Research ?
Sign-up Next time we write about Florida Institute for the Commercialization of Public Research, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.